Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma
Yun‐Fan Sun, Pin Wu, Zefan Zhang, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 135-156.e17
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Lactylome Analysis Unveils Lactylation‐Dependent Mechanisms of Stemness Remodeling in the Liver Cancer Stem Cells
Fan Feng, Jiaqin Wu, Qingjia Chi, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 32
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Advances in spatial transcriptomics and its applications in cancer research
Huazhe Yang, Yuanli Zuo, Gang Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Tumour hypoxia in driving genomic instability and tumour evolution
Alexandru Suvac, Jack Ashton, Robert G. Bristow
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 1
Lactate Drives Senescence-Resistant Lineages in Hepatocellular Carcinoma via Histone H2B Lactylation of NDRG1
Lu Li, Jinyun Dong, Chunwei Xu, et al.
Cancer Letters (2025), pp. 217567-217567
Closed Access | Times Cited: 1
Molecular mechanisms of m6A modifications regulating tumor radioresistance
Ruolin Shen, Zhenyang Jiang, Huanhuan Wang, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Applications of single-cell multi-omics in liver cancer
Frederik Peeters, Sarah Cappuyns, Marta Piqué‐Gili, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101094-101094
Open Access | Times Cited: 6
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Downregulation of hnRNPA1 inhibits hepatocellular carcinoma cell progression by modulating alternative splicing of ZNF207 exon 9
Qi Ouyang, Wenhui He, Yiping Guo, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Mechanisms and Strategies of Immunosenescence Effects on Non-Small Cell Lung Cancer (NSCLC) Treatment: A Comprehensive Analysis and Future Directions
Huatao Zhou, Zilong Zheng, Chengming Fan, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 44-66
Closed Access
Integrating single-cell RNA-Seq and bulk RNA-Seq data to explore the key role of fatty acid metabolism in hepatocellular carcinoma
Hua Dai, Tao Xin, Yongqian Shu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Maintaining first-line therapy plus radiotherapy may prolong progression-free survival and delay second-line therapy for oligoprogressive hepatocellular carcinoma
Boyu Leng, Haohua Wang, Yucheng Ge, et al.
International Journal of Radiation Oncology*Biology*Physics (2025)
Open Access
TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
Jin Li, Ling Bai, Zhaodan Xin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Optimizing interventional therapy: A homogeneous lipiodol formulation of Tirapazamine and Sorafenib responsive to post-embolization microenvironment
Xing Gao, Hongwei Cheng, Minglei Teng, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 879-889
Closed Access
Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Deep Learning in Oncology: Transforming Cancer Diagnosis, Prognosis, and Treatment
Thaís Santos Anjo Reis
Emerging Trends in Drugs Addictions and Health (2025), pp. 100171-100171
Open Access
Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells
Zebo Jiang, Qiang He, Liping Kang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
From morphology to single-cell molecules: high-resolution 3D histology in biomedicine
Xintian Xu, Jimeng Su, Rongyi Zhu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities
Xiling Liu, Xichun Kang, Haiyan Kang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Suppressor of cytokine signaling 2 modulates regulatory T cell activity to suppress liver hepatocellular carcinoma growth and metastasis
Xi Lan, Heng Zhang, Z. Chen, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 13
Closed Access
Decoding Hepatocellular Carcinoma Metastasis: Molecular Mechanisms, Targeted Therapies, and Potential Biomarkers
Ke Wei, Chunxiu Peng, Yang Ou, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 263-263
Open Access
In vivo armed macrophages curb liver metastasis through tumor-reactive T-cell rejuvenation
Marco Notaro, Marco Borghetti, Chiara Bresesti, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Spatial oncology: Translating contextual biology to the clinic
Dennis Gong, Jeanna M Arbesfeld-Qiu, Ella Perrault, et al.
Cancer Cell (2024)
Closed Access | Times Cited: 4
Emerging trends and hot topics in the application of multi-omics in drug discovery: A bibliometric and visualized study
Ziheng Wang, Yang Zhao, Long Zhang
Current Pharmaceutical Analysis (2024) Vol. 21, Iss. 1, pp. 20-32
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top